Cetera Investment Advisers Purchases 7,235 Shares of Cabot Co. (NYSE:CBT)

Cetera Investment Advisers boosted its holdings in Cabot Co. (NYSE:CBT - Free Report) by 60.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,241 shares of the specialty chemicals company's stock after buying an additional 7,235 shares during the period. Cetera Investment Advisers' holdings in Cabot were worth $1,757,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of CBT. Norges Bank acquired a new stake in Cabot during the fourth quarter worth about $37,961,000. Copeland Capital Management LLC grew its holdings in shares of Cabot by 21.6% during the 4th quarter. Copeland Capital Management LLC now owns 761,372 shares of the specialty chemicals company's stock worth $69,521,000 after purchasing an additional 135,119 shares in the last quarter. American Century Companies Inc. increased its position in shares of Cabot by 8.5% during the fourth quarter. American Century Companies Inc. now owns 1,323,347 shares of the specialty chemicals company's stock valued at $120,835,000 after purchasing an additional 103,380 shares during the period. JPMorgan Chase & Co. increased its position in shares of Cabot by 27.1% during the fourth quarter. JPMorgan Chase & Co. now owns 451,513 shares of the specialty chemicals company's stock valued at $41,228,000 after purchasing an additional 96,179 shares during the period. Finally, Northern Trust Corp raised its stake in shares of Cabot by 12.4% in the fourth quarter. Northern Trust Corp now owns 794,477 shares of the specialty chemicals company's stock valued at $72,544,000 after purchasing an additional 87,881 shares in the last quarter. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Cabot Price Performance

Shares of NYSE:CBT traded up $0.02 on Friday, hitting $74.07. The stock had a trading volume of 450,376 shares, compared to its average volume of 408,110. The firm's 50 day moving average price is $78.45 and its 200-day moving average price is $88.92. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.29 and a current ratio of 2.00. Cabot Co. has a twelve month low of $71.64 and a twelve month high of $117.46. The company has a market capitalization of $3.98 billion, a price-to-earnings ratio of 9.84, a price-to-earnings-growth ratio of 0.74 and a beta of 0.91.

Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The specialty chemicals company reported $1.90 EPS for the quarter, beating analysts' consensus estimates of $1.86 by $0.04. The firm had revenue of $936.00 million for the quarter, compared to analyst estimates of $1.02 billion. Cabot had a net margin of 10.60% and a return on equity of 26.79%. The company's revenue for the quarter was down 8.1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.78 earnings per share. On average, equities research analysts predict that Cabot Co. will post 7.57 earnings per share for the current year.

Cabot Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 30th will be issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.43%. This is a boost from Cabot's previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Friday, May 30th. Cabot's dividend payout ratio (DPR) is currently 23.29%.

Analyst Ratings Changes

CBT has been the topic of several analyst reports. Wall Street Zen lowered shares of Cabot from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. UBS Group lowered their target price on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a research note on Monday, April 7th. Finally, JPMorgan Chase & Co. decreased their price objective on Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a report on Friday, February 21st.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.